Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Edith Canby-Hagino"'
Autor:
Jeffrey D. Forman, E. David Crawford, Gregory P. Swanson, Ian M. Thompson, Edith Canby-Hagino, Edward M. Messing, Catherine M. Tangen, Bryan Goldman, Joseph L. Chin
Publikováno v:
Journal of Urology. 180:2453-2458
Purpose: From the randomized study Southwest Oncology Group 8794 we evaluated the effect of seminal vesicle involvement on outcomes and whether those patients benefited from post-prostatectomy adjuvant radiation therapy.Materials and Methods: Southwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80ac23858de64aff342dc8cedb77a1fc
https://doi.org/10.1016/j.juro.2008.08.037
https://doi.org/10.1016/j.juro.2008.08.037
Publikováno v:
Current Urology Reports. 8:185-189
The number of men for whom testosterone is prescribed is rapidly increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adipos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f350facf8c1889b61a7ae38ba0d3c0f2
https://doi.org/10.1007/s11934-007-0004-x
https://doi.org/10.1007/s11934-007-0004-x
Publikováno v:
European Urology. 51:27-33
Objectives: Provide a critical summary of the latest interpretation of findings from the Prostate Cancer Prevention Trial (PCPT). Methods: Findings from PCPT and recently published post-hoc analyses are reviewed. Results: PCPT demonstrated that finas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::351917a490e5deafde9e3adda6f5dbdd
https://doi.org/10.1016/j.eururo.2006.09.002
https://doi.org/10.1016/j.eururo.2006.09.002
Autor:
Edith Canby-Hagino, Rita Ghosh, Ian M. Thompson, A. Pratap Kumar, Robin J. Leach, Timothy C. Brand
Publikováno v:
Hematology/Oncology Clinics of North America. 20:831-843
Prostate cancer is a common malignancy with multiple potential opportunities for cancer prevention. As the genetic basis of this malignancy is further understood, prevention strategies will be developed for individual patients based on specific risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e67c1e41cba17c144f2e4df9f709c88e
https://doi.org/10.1016/j.hoc.2006.03.012
https://doi.org/10.1016/j.hoc.2006.03.012
Publikováno v:
Expert Opinion on Pharmacotherapy. 7:899-905
Prostate cancer is a significant cause of disease and death, making it an attractive target for chemoprevention. The association between lifetime exposure to dihydrotestosterone and risk of developing prostate cancer suggests that chemoprevention is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b438755b18b15191e90ce02b57df4616
https://doi.org/10.1517/14656566.7.7.899
https://doi.org/10.1517/14656566.7.7.899
Publikováno v:
Surgical Oncology Clinics of North America. 14:747-760
Prostate cancer screening with PSA and with digital rectal examination isa reality in the United States. Regardless of recent observations regarding the complexities of PSA interpretation, millions of U.S. men expect an annual PSA test and physicians
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6aa29a23c575aa7e53d6dbc5f8bc697
https://doi.org/10.1016/j.soc.2005.07.001
https://doi.org/10.1016/j.soc.2005.07.001
Publikováno v:
Journal of Urology. 174:553-556
Since the advent of widespread prostate specific antigen (PSA) based screening in the United States, the risk of over diagnosis as well as delayed diagnosis due to existing PSA thresholds has become a concern. Treatment decision planning is generally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87bdeeba19b692cd9b76441a4b1e8453
https://doi.org/10.1097/01.ju.0000165184.72337.9d
https://doi.org/10.1097/01.ju.0000165184.72337.9d
Publikováno v:
Current Urology Reports. 6:171-176
Recent studies have cast doubt on the reliability of serum total prostate-specific antigen as a biomarker for the detection and prognosis of prostate cancer. Biomarkers that can identify those men at risk for clinically significant prostate cancer ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c65148b1d67909c163858eed6bd813
https://doi.org/10.1007/s11934-005-0004-7
https://doi.org/10.1007/s11934-005-0004-7
Autor:
Ian M. Thompson, Bruce A. Lowe, Eric A. Klein, Isaac J. Powell, Catherine M. Tangen, Edith Canby-Hagino, Ryan K. Berglund, E. David Crawford, Peter R. Carroll, George P. Hemstreet, Gabriel P. Haas, Ralph W deVere White
Objective To update the results with 10-year data of a phase II prospective trial of neoadjuvant hormonal therapy with goserelin acetate and flutamide followed by radical prostatectomy for locally advanced prostate cancer (SWOG 9109). The optimal man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9131432ce288904d6ac9c96bed08c56d
https://europepmc.org/articles/PMC3839235/
https://europepmc.org/articles/PMC3839235/
Autor:
Brian C. Griffith, Edith Canby-Hagino, Allen F. Morey, Thomas A. Rozanski, John P. Foley, Mustafa M. Ali-Khan
Publikováno v:
The Journal of Urology. :1021-1023
Purpose: We determine if a single 500 mg. oral tablet of levofloxacin represents adequate prophylaxis for patients at low risk who undergo transrectal prostate biopsy.Materials and Methods: From April 2000 to May 2001 we prospectively evaluated 400 c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::228291bebd8b9c8e09e87ce554e0585e
https://doi.org/10.1097/00005392-200209000-00028
https://doi.org/10.1097/00005392-200209000-00028